J3060 Injection, taliglucerase alfa 10 u
Also known as: taliglucerase, Elelyso, enzyme replacement therapy
Taliglucerase alfa (Elelyso) 10 units injection is a recombinant enzyme replacement therapy for Gaucher disease, a lysosomal storage disorder affecting glucocerebroside metabolism.
In Plain Language
genetic storage disease treatment; enzyme replacement infusion
Clinical Context
Used in Gaucher disease Type 1 and Type 3 patients with visceral and hematologic manifestations. Reduces hepatosplenomegaly and bone disease. Administered intravenously as enzyme replacement therapy.
RVU Information
CPT J3060 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.
Billing & Documentation
J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.
Specialties
Frequently Asked Questions
What is CPT code J3060?
CPT J3060 (Injection, taliglucerase alfa 10 u) is a J Codes (Drugs) code. Taliglucerase alfa (Elelyso) 10 units injection is a recombinant enzyme replacement therapy for Gaucher disease, a lysosomal storage disorder affecting glucocerebroside metabolism.
How is J3060 administered?
CPT J3060 is administered by a healthcare provider, typically via injection or infusion. Used in Gaucher disease Type 1 and Type 3 patients with visceral and hematologic manifestations. Reduces hepatosplenomegaly and bone disease. Administered intravenously as enzyme replacement therapy. It is used by Hematology/Oncology, Rare Disease Specialists, Genetic Medicine.
When is CPT J3060 used?
Used in Gaucher disease Type 1 and Type 3 patients with visceral and hematologic manifestations. Reduces hepatosplenomegaly and bone disease. Administered intravenously as enzyme replacement therapy.
Track This Code in RVU Edge
Log procedures, calculate wRVUs, and benchmark against MGMA data — all in one app.
CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.